Literature DB >> 32914075

Kidney transplantation from a living donor with renal artery fibromuscular dysplasia: A case report on arterial grafting of the donor renal artery.

Yuto Matsushita1, Daisuke Motoyama1, Toshiki Ito1, Takayuki Sugiyama1, Atsushi Otsuka1, Masaki Sano2, Kazunori Inuzuka2, Hideaki Miyake1.   

Abstract

INTRODUCTION: Renal artery fibromuscular dysplasia is generally considered a contraindication of kidney transplantation, since fibromuscular dysplasia occasionally induces hypertension or renal insufficiency in the recipient and/or donor. To date, limited information remains available with respect to whether kidneys with renal arterial fibromuscular dysplasia can be successfully transplanted. CASE
PRESENTATION: A 53-year-old potential donor was diagnosed with fibromuscular dysplasia of the right renal artery. Laparoscopic right nephrectomy was performed, and the affected portion was resected and reconstructed using the harvested internal iliac artery. Transplantation was successful and the serum creatinine level was <2 mg/dL for 3 years after surgery.
CONCLUSION: If reconstruction of the diseased artery could be safely performed, transplantation using a kidney from a donor with renal artery fibromuscular dysplasia may be considered.
© 2020 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.

Entities:  

Keywords:  arterial graft; fibromuscular dysplasia; living donor kidney transplantation

Year:  2020        PMID: 32914075      PMCID: PMC7469844          DOI: 10.1002/iju5.12188

Source DB:  PubMed          Journal:  IJU Case Rep        ISSN: 2577-171X


computed tomography effective renal plasma flow fibromuscular dysplasia Even if a kidney is received from a donor with FMD, kidney transplantation incorporating reconstruction of the affected renal artery could be successfully performed. However, careful long‐term follow‐up for both donors and recipients is necessary to ensure favorable renal function.

Introduction

Renal artery FMD is an idiopathic disease accompanied by distorted architecture of the renal arterial wall. In potential kidney transplant donors, the incidence of renal artery FMD has been reported to be 2.0–6.6%. , , , Kidney transplantation from donors with FMD is generally regarded as a contraindication, because it may cause hypertension and renal insufficiency not only in the recipient but also in the donor. However, considering the chronic shortage of organ donations for renal transplantation, it is necessary to develop a safe strategy for the use of kidneys with renal artery FMD. Here, we describe a successful living donor renal transplantation using a kidney with renal artery FMD by incorporating the reconstruction of the artery.

Case presentation

A 53‐year‐old woman was admitted to donate one of her kidneys to her husband. Contrast‐enhanced CT revealed irregular lumen in the right renal artery (Fig. 1); however, she had normal blood pressure and a blood test indicated normal renin activity and aldosterone level. Renal arteriography visualized a 15‐mm long string‐of‐beads pattern at the proximal right renal artery (Fig. 2), while the rest of the distal right renal artery and the whole left renal artery appeared intact. Based on these findings, she was diagnosed with moderate renal artery FMD. A renogram with technetium‐99m mercaptoacetyltriglycine revealed that the ERPFs of the right and left kidneys were 48.4 and 64.1 mL/min, respectively. Considering the laterality of FMD as well as the difference of ERPF, her right kidney was judged to be suitable as a graft kidney.
Fig. 1

Contrast‐enhanced CT showing irregular lumen of the right renal artery (arrow).

Fig. 2

Renal arteriography revealing 15‐mm long string‐of‐beads pattern at the main right renal artery.

Contrast‐enhanced CT showing irregular lumen of the right renal artery (arrow). Renal arteriography revealing 15‐mm long string‐of‐beads pattern at the main right renal artery. Laparoscopic right donor nephrectomy by the retroperitoneal approach and kidney transplantation to the recipient were performed. Following the removal of the donor kidney, we resected 20 mm of the right renal artery, including 15 mm of the diseased portion documented by preoperative imaging examinations, considering the finding of intraoperative palpation. The renal artery was then reconstructed using a graft of the internal iliac artery and its brunch harvested from the recipient on extracorporeal surgery. As shown in Figure 3a, end‐to‐end anastomosis between the donor renal artery and arterial graft was performed at two proximal sites using the interrupted suture. Then, the graft kidney was transplanted in the right iliac fossa by vascular anastomoses with arterial graft to the internal iliac artery in an end‐to‐end fashion and the renal vein to the external iliac vein in an end‐to‐side fashion. In this case, the warm ischemia time and cold ischemia time were 3 and 147 min, respectively. Affected artery was pathologically diagnosed with medial‐type FMD, characterized by fibroplasia in the arterial medium and proliferation of smooth muscle tissue cells (Fig. 3b).
Fig. 3

(a) The renal artery was reconstructed by a graft of the internal iliac artery and its brunch harvested from the recipient. End‐to‐end anastomosis was performed using a single‐stitch technique (arrows). (b) Elastica van Gieson staining of the right renal artery indicated fibroplasia in the arterial medium and proliferation of smooth muscle tissue cells.

(a) The renal artery was reconstructed by a graft of the internal iliac artery and its brunch harvested from the recipient. End‐to‐end anastomosis was performed using a single‐stitch technique (arrows). (b) Elastica van Gieson staining of the right renal artery indicated fibroplasia in the arterial medium and proliferation of smooth muscle tissue cells. After transplantation, the subsequent courses in both the donor and recipient were surgically unremarkable, and the renal graft functioned favorably with a serum creatinine level of 1.6 mg/dL, resulting in the withdrawal of hemodialysis. The renal graft function was stable with a serum creatinine level of <2 mg/dL for 3 years after transplantation in the recipient, and blood pressure in both the donor and recipient was normal without medication.

Discussion

FMD is a non‐atherosclerotic disease of the musculature of arteries accompanied by abnormal cellular proliferation. To diagnose FMD, computed tomographic angiography is initially performed; however, it is necessary to conduct catheter‐based angiography to obtain precise findings on location and morphological features. Despite being frequently asymptomatic, FMD can cause renovascular hypertension and is managed by medication against hypertension, angioplasty by catheter, and/or surgery. The prevalence of renal artery FMD is 2.0–6.6% of the potential donor population. , , , However, the guidelines for living kidney donors developed in the Amsterdam Forum did not mention the eligibility of donor candidates with FMD. Although renal artery FMD is usually regarded as a contraindication of kidney transplantation considering the potential risks of postoperative hypertension and renal insufficiency in both the donor and recipient, there have been reports of successful cases. Kolettis et al. conducted a retrospective review of a departmental database of renal transplantations, and identified 36 donors with FMD. After transplantation, recipients from these donors achieved functional outcomes similar to those from non‐FMD donors under adequate preoperative assessment including arteriography. Based on these findings, they concluded that selected patients with renal artery FMD who showed normal blood pressure and medial‐type FMD could be donors for renal transplantation. Pfeiffer et al. also found that even kidneys from donors with severe renal artery FMD could be successfully transplanted, if the affected renal artery segments could be precisely reconstructed. In our case, although moderate FMD was present at the proximal right renal artery, it was assumed that the affected segment could be reconstructed by arterial grafting according to the assessments of preoperative examinations. FMD was only detected unilaterally, and the contralateral renal artery lacked signs of FMD; therefore, the removal of the affected kidney by FMD could result in a reduced risk of future development of hypertension in the donor. Considering these findings, we decided to transplant the kidney. Although Pfeiffer et al. recommended vein graft replacement as the most suitable method, considering the comparatively high perioperative risk of bleeding complications after reconstruction of the renal artery with a harvested vein, arterial replacement could be a safe alternative in such cases. Indeed, despite being an initial case using the internal iliac artery as a graft vessel, this case exhibited a favorable perioperative course without complications. Although there were some studies showing the contralateral kidney remained free from FMD in patients donated the affected kidneys, , we would like to emphasize the importance of a long‐term careful follow‐up for both the donor and recipient after renal transplantation, considering the possibility of developing postoperative FMD. Parasuraman et al. reported a living kidney donor affected by renovascular hypertension 1 year after donation. She was not diagnosed with FMD before donation, but retrospective careful review of preoperative CT indicated very mild arterial stenosis. Bonatti et al. also described a donor affected with hypertension and renal dysfunction by the FMD 8 years after donation. In addition to living donor transplantation, several cases after deceased donor transplantation were treated with percutaneous transluminal angioplasty. , , , Due to the difficulty of preoperative precise assessment, intensive observation is important particularly after renal transplantation from deceased donor. In this report, we described a successfully performed living donor renal transplantation from a donor with moderate FMD of the renal artery by reconstructing the affected artery using the internal iliac artery harvested from the recipient. Based on this case, the use of kidneys from donors with FMD should be considered, resulting in a contribution to increase the donor pool and to decrease waiting time for renal transplantation. However, it should be recognized that the transplantation of a kidney from a donor with FMD is a technically challenging operation requiring vascular surgical expertise; thus, collaboration with a vascular surgeon may be necessary in some institutions.

Conflict of interest

The authors declare no conflict of interest.
  16 in total

1.  Even severe renal artery fibromuscular dysplasia is no contraindication for living donor renal transplantation: report of two successful cases with venous grafting of the donor renal artery.

Authors:  T Pfeiffer; H Böhner; A Voiculescu; M Sarbia; B Grabensee; W Sandmann
Journal:  Transplant Proc       Date:  2002-12       Impact factor: 1.066

2.  Fibromuscular dysplasia of the right kidney in a woman who donated her left kidney.

Authors:  Hugo Bonatti; Nancy L Harthun; Rajeev Sharma; Kenneth Brayman; Robert G Sawyer; Klaus D Hagspiel
Journal:  Transpl Int       Date:  2010-01-12       Impact factor: 3.782

3.  Live donor nephrectomy in patients with fibromuscular dysplasia of the renal arteries.

Authors:  R Indudhara; A J Bueschen; J R Burns
Journal:  J Urol       Date:  1999-09       Impact factor: 7.450

4.  Images in nephrology. Fibromuscular dysplasia in a transplanted kidney.

Authors:  C Campieri; M Gregorini; M R Moschella; C Perna; C Rossi; S Stefoni; V Bonomini
Journal:  Nephrol Dial Transplant       Date:  1998-05       Impact factor: 5.992

5.  Fibromuscular dysplasia and renal transplantation.

Authors:  Joseph Y Young; Robert K Ryu; David D Casalino
Journal:  J Urol       Date:  2011-07-23       Impact factor: 7.450

Review 6.  First International Consensus on the diagnosis and management of fibromuscular dysplasia.

Authors:  Heather L Gornik; Alexandre Persu; David Adlam; Lucas S Aparicio; Michel Azizi; Marion Boulanger; Rosa Maria Bruno; Peter de Leeuw; Natalia Fendrikova-Mahlay; James Froehlich; Santhi K Ganesh; Bruce H Gray; Cathlin Jamison; Andrzej Januszewicz; Xavier Jeunemaitre; Daniella Kadian-Dodov; Esther Sh Kim; Jason C Kovacic; Pamela Mace; Alberto Morganti; Aditya Sharma; Andrew M Southerland; Emmanuel Touzé; Patricia van der Niepen; Jiguang Wang; Ido Weinberg; Scott Wilson; Jeffrey W Olin; Pierre-Francois Plouin
Journal:  Vasc Med       Date:  2019-01-16       Impact factor: 3.239

7.  Arteriographic detection of renovascular disease in potential renal donors: incidence and effect on donor surgery.

Authors:  E Neymark; J M LaBerge; R Hirose; J S Melzer; R K Kerlan; M W Wilson; R L Gordon
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

Review 8.  A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines.

Authors:  Francis Delmonico
Journal:  Transplantation       Date:  2005-03-27       Impact factor: 4.939

9.  Outcomes for live donor renal transplantation using kidneys with medial fibroplasia.

Authors:  Peter N Kolettis; Charles E Bugg; Mark E Lockhart; Steven J Bynon; John R Burns
Journal:  Urology       Date:  2004-04       Impact factor: 2.649

10.  Is fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in CORAL trial participants versus a single institution population of renal donor candidates.

Authors:  Nicholas J Hendricks; Alan H Matsumoto; John F Angle; Aparna Baheti; Saher S Sabri; Auh W Park; James R Stone; James T Patrie; Lance Dworkin; Christopher J Cooper; Timothy P Murphy; Donald E Cutlip
Journal:  Vasc Med       Date:  2014-07-31       Impact factor: 3.239

View more
  1 in total

1.  Kidney transplantation from living donor with monolateral renal artery fibromuscular dysplasia using a cryopreserved iliac graft for arterial reconstruction: a case report and review of the literature.

Authors:  Rostand Emmanuel Nguefouet Momo; Paola Donato; Gabriele Ugolini; Francesco Nacchia; Luca Mezzetto; Gian Franco Veraldi; Stefano Marletta; Enrico Cavallo; Albino Eccher; Annamaria Giambanco; Daniela Cenzi; Luigino Boschiero
Journal:  BMC Nephrol       Date:  2020-10-28       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.